APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccine Treatment

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

Selected research

Market Analysis & Forecast

Global Tuberculosis Vaccine Treatment Market Analysis and Forecast 2026-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccine Treatment Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccine Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccine Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccine Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccine Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

Read the full market overview

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

This report presents an overview of global market for Tuberculosis Vaccine Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tuberculosis Vaccine Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Tuberculosis Vaccine Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis Vaccine Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tuberculosis Vaccine Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tuberculosis Vaccine Treatment sales, projected growth trends, production technology, application and end-user industry.

Tuberculosis Vaccine Treatment Segment by Company

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC

Queen Saovabha Mem. Inst

Microgen

Tuberculosis Vaccine Treatment Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Vaccine Treatment Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Vaccine Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tuberculosis Vaccine Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Vaccine Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune Vaccine Major Manufacturers Table 3. Therapy Vaccine Major Manufacturers Table 4. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Self-Procurement Major Manufacturers Table 6. UNICEF Major Manufacturers Table 7. Other Major Manufacturers Table 8. Tuberculosis Vaccine Treatment Industry Trends Table 9. Tuberculosis Vaccine Treatment Industry Drivers Table 10. Tuberculosis Vaccine Treatment Industry Opportunities and Challenges Table 11. Tuberculosis Vaccine Treatment Industry Restraints Table 12. Global Tuberculosis Vaccine Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Tuberculosis Vaccine Treatment Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Tuberculosis Vaccine Treatment Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2021-2026) Table 16. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2027-2032) Table 17. Global Tuberculosis Vaccine Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Dose) Table 18. Global Tuberculosis Vaccine Treatment Sales by Region (2021-2026) & (K Dose) Table 19. Global Tuberculosis Vaccine Treatment Sales by Region (2027-2032) & (K Dose) Table 20. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2021-2026) Table 21. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2027-2032) Table 22. Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Tuberculosis Vaccine Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2021-2026) Table 26. Global Tuberculosis Vaccine Treatment Sales Price (USD/K Dose) of Manufacturers (2021-2026) Table 27. Global Tuberculosis Vaccine Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Tuberculosis Vaccine Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Tuberculosis Vaccine Treatment Manufacturers, Product Type & Application Table 30. Global Tuberculosis Vaccine Treatment Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Tuberculosis Vaccine Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Tuberculosis Vaccine Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2021-2026) Table 37. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2027-2032) Table 38. Global Tuberculosis Vaccine Treatment Sales by Type 2021 VS 2025 VS 2032 (K Dose) Table 39. Global Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 40. Global Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 41. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2021-2026) Table 42. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2027-2032) Table 43. Global Tuberculosis Vaccine Treatment Price by Type (2021-2026) & (USD/K Dose) Table 44. Global Tuberculosis Vaccine Treatment Price by Type (2027-2032) & (USD/K Dose) Table 45. Global Tuberculosis Vaccine Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2021-2026) Table 49. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2027-2032) Table 50. Global Tuberculosis Vaccine Treatment Sales by Application 2021 VS 2025 VS 2032 (K Dose) Table 51. Global Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 52. Global Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 53. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2021-2026) Table 54. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2027-2032) Table 55. Global Tuberculosis Vaccine Treatment Price by Application (2021-2026) & (USD/K Dose) Table 56. Global Tuberculosis Vaccine Treatment Price by Application (2027-2032) & (USD/K Dose) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 60. Merck Tuberculosis Vaccine Treatment Product Portfolio Table 61. Merck Recent Development Table 62. Japan BCG Lab Company Information Table 63. Japan BCG Lab Business Overview Table 64. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 65. Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio Table 66. Japan BCG Lab Recent Development Table 67. Serum Institute of India Company Information Table 68. Serum Institute of India Business Overview Table 69. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 70. Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio Table 71. Serum Institute of India Recent Development Table 72. AJ Vaccines Company Information Table 73. AJ Vaccines Business Overview Table 74. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 75. AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio Table 76. AJ Vaccines Recent Development Table 77. BioFarma Company Information Table 78. BioFarma Business Overview Table 79. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 80. BioFarma Tuberculosis Vaccine Treatment Product Portfolio Table 81. BioFarma Recent Development Table 82. GreenSignal Bio Pharma Company Information Table 83. GreenSignal Bio Pharma Business Overview Table 84. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 85. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio Table 86. GreenSignal Bio Pharma Recent Development Table 87. China National Biotec Company Information Table 88. China National Biotec Business Overview Table 89. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 90. China National Biotec Tuberculosis Vaccine Treatment Product Portfolio Table 91. China National Biotec Recent Development Table 92. Biomed Lublin Company Information Table 93. Biomed Lublin Business Overview Table 94. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 95. Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio Table 96. Biomed Lublin Recent Development Table 97. Taj Pharmaceuticals Company Information Table 98. Taj Pharmaceuticals Business Overview Table 99. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 100. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio Table 101. Taj Pharmaceuticals Recent Development Table 102. Ataulpho de Paiva Company Information Table 103. Ataulpho de Paiva Business Overview Table 104. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 105. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio Table 106. Ataulpho de Paiva Recent Development Table 107. IVAC Company Information Table 108. IVAC Business Overview Table 109. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 110. IVAC Tuberculosis Vaccine Treatment Product Portfolio Table 111. IVAC Recent Development Table 112. Queen Saovabha Mem. Inst Company Information Table 113. Queen Saovabha Mem. Inst Business Overview Table 114. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 115. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio Table 116. Queen Saovabha Mem. Inst Recent Development Table 117. Microgen Company Information Table 118. Microgen Business Overview Table 119. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2021-2026) Table 120. Microgen Tuberculosis Vaccine Treatment Product Portfolio Table 121. Microgen Recent Development Table 122. North America Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 125. North America Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 126. North America Tuberculosis Vaccine Treatment Sales Price by Type (2021-2026) & (USD/K Dose) Table 127. North America Tuberculosis Vaccine Treatment Sales Price by Type (2027-2032) & (USD/K Dose) Table 128. North America Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 131. North America Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 132. North America Tuberculosis Vaccine Treatment Sales Price by Application (2021-2026) & (USD/K Dose) Table 133. North America Tuberculosis Vaccine Treatment Sales Price by Application (2027-2032) & (USD/K Dose) Table 134. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 138. North America Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 139. North America Tuberculosis Vaccine Treatment Sales by Country (2027-2032) & (K Dose) Table 140. North America Tuberculosis Vaccine Treatment Sales Price by Country (2021-2026) & (USD/K Dose) Table 141. North America Tuberculosis Vaccine Treatment Sales Price by Country (2027-2032) & (USD/K Dose) Table 142. United States Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 143. Canada Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 144. Mexico Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 145. Europe Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 148. Europe Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 149. Europe Tuberculosis Vaccine Treatment Sales Price by Type (2021-2026) & (USD/K Dose) Table 150. Europe Tuberculosis Vaccine Treatment Sales Price by Type (2027-2032) & (USD/K Dose) Table 151. Europe Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 154. Europe Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 155. Europe Tuberculosis Vaccine Treatment Sales Price by Application (2021-2026) & (USD/K Dose) Table 156. Europe Tuberculosis Vaccine Treatment Sales Price by Application (2027-2032) & (USD/K Dose) Table 157. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 161. Europe Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 162. Europe Tuberculosis Vaccine Treatment Sales by Country (2027-2032) & (K Dose) Table 163. Europe Tuberculosis Vaccine Treatment Sales Price by Country (2021-2026) & (USD/K Dose) Table 164. Europe Tuberculosis Vaccine Treatment Sales Price by Country (2027-2032) & (USD/K Dose) Table 165. Germany Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 166. France Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 167. U.K. Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 168. Italy Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 169. Russia Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 170. Spain Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 173. Sweden Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 174. Poland Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 175. China Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 176. China Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 177. China Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 178. China Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 179. China Tuberculosis Vaccine Treatment Sales Price by Type (2021-2026) & (USD/K Dose) Table 180. China Tuberculosis Vaccine Treatment Sales Price by Type (2027-2032) & (USD/K Dose) Table 181. China Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 182. China Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 183. China Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 184. China Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 185. China Tuberculosis Vaccine Treatment Sales Price by Application (2021-2026) & (USD/K Dose) Table 186. China Tuberculosis Vaccine Treatment Sales Price by Application (2027-2032) & (USD/K Dose) Table 187. Asia Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 190. Asia Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 191. Asia Tuberculosis Vaccine Treatment Sales Price by Type (2021-2026) & (USD/K Dose) Table 192. Asia Tuberculosis Vaccine Treatment Sales Price by Type (2027-2032) & (USD/K Dose) Table 193. Asia Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 196. Asia Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 197. Asia Tuberculosis Vaccine Treatment Sales Price by Application (2021-2026) & (USD/K Dose) Table 198. Asia Tuberculosis Vaccine Treatment Sales Price by Application (2027-2032) & (USD/K Dose) Table 199. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 203. Asia Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 204. Asia Tuberculosis Vaccine Treatment Sales by Country (2027-2032) & (K Dose) Table 205. Asia Tuberculosis Vaccine Treatment Sales Price by Country (2021-2026) & (USD/K Dose) Table 206. Asia Tuberculosis Vaccine Treatment Sales Price by Country (2027-2032) & (USD/K Dose) Table 207. Japan Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 208. South Korea Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 209. India Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 210. Australia Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Tuberculosis Vaccine Treatment Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Tuberculosis Vaccine Treatment Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Tuberculosis Vaccine Treatment Sales by Type (2021-2026) & (K Dose) Table 216. SAMEA Tuberculosis Vaccine Treatment Sales by Type (2027-2032) & (K Dose) Table 217. SAMEA Tuberculosis Vaccine Treatment Sales Price by Type (2021-2026) & (USD/K Dose) Table 218. SAMEA Tuberculosis Vaccine Treatment Sales Price by Type (2027-2032) & (USD/K Dose) Table 219. SAMEA Tuberculosis Vaccine Treatment Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Tuberculosis Vaccine Treatment Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Tuberculosis Vaccine Treatment Sales by Application (2021-2026) & (K Dose) Table 222. SAMEA Tuberculosis Vaccine Treatment Sales by Application (2027-2032) & (K Dose) Table 223. SAMEA Tuberculosis Vaccine Treatment Sales Price by Application (2021-2026) & (USD/K Dose) Table 224. SAMEA Tuberculosis Vaccine Treatment Sales Price by Application (2027-2032) & (USD/K Dose) Table 225. SAMEA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 229. SAMEA Tuberculosis Vaccine Treatment Sales by Country (2021-2026) & (K Dose) Table 230. SAMEA Tuberculosis Vaccine Treatment Sales by Country (2027-2032) & (K Dose) Table 231. SAMEA Tuberculosis Vaccine Treatment Sales Price by Country (2021-2026) & (USD/K Dose) Table 232. SAMEA Tuberculosis Vaccine Treatment Sales Price by Country (2027-2032) & (USD/K Dose) Table 233. Brazil Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 234. Argentina Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 235. Chile Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 236. Colombia Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 237. Peru Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 239. Israel Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 240. UAE Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 241. Turkey Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 242. Iran Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 243. Egypt Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Tuberculosis Vaccine Treatment Distributors List Table 247. Tuberculosis Vaccine Treatment Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Treatment Image Figure 2. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccine Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune Vaccine Image Figure 5. Therapy Vaccine Image Figure 6. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tuberculosis Vaccine Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Self-Procurement Image Figure 9. UNICEF Image Figure 10. Other Image Figure 11. Global Tuberculosis Vaccine Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tuberculosis Vaccine Treatment Revenue (2021-2032) & (US$ Million) Figure 13. Global Tuberculosis Vaccine Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2021-2032) Figure 16. Global Tuberculosis Vaccine Treatment Sales (2021-2032) & (K Dose) Figure 17. Global Tuberculosis Vaccine Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Tuberculosis Vaccine Treatment Sales YoY (2021-2032) & (K Dose) Figure 20. Europe Tuberculosis Vaccine Treatment Sales YoY (2021-2032) & (K Dose) Figure 21. China Tuberculosis Vaccine Treatment Sales YoY (2021-2032) & (K Dose) Figure 22. Asia (Excluding China) Tuberculosis Vaccine Treatment Sales YoY (2021-2032) & (K Dose) Figure 23. South America, Middle East and Africa Tuberculosis Vaccine Treatment Sales YoY (2021-2032) & (K Dose) Figure 24. Global Tuberculosis Vaccine Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Tuberculosis Vaccine Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Tuberculosis Vaccine Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2021-2032) Figure 30. Global Tuberculosis Vaccine Treatment Sales by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 31. Global Tuberculosis Vaccine Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2021-2032) Figure 33. Global Tuberculosis Vaccine Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2021-2032) Figure 36. Global Tuberculosis Vaccine Treatment Sales by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 37. Global Tuberculosis Vaccine Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2021-2032) Figure 39. North America Tuberculosis Vaccine Treatment Revenue Share by Type (2021-2032) Figure 40. North America Tuberculosis Vaccine Treatment Sales Share by Type (2021-2032) Figure 41. North America Tuberculosis Vaccine Treatment Revenue Share by Application (2021-2032) Figure 42. North America Tuberculosis Vaccine Treatment Sales Share by Application (2021-2032) Figure 43. North America Tuberculosis Vaccine Treatment Revenue Share by Country (2021-2032) Figure 44. North America Tuberculosis Vaccine Treatment Sales Share by Country (2021-2032) Figure 45. Europe Tuberculosis Vaccine Treatment Revenue Share by Type (2021-2032) Figure 46. Europe Tuberculosis Vaccine Treatment Sales Share by Type (2021-2032) Figure 47. Europe Tuberculosis Vaccine Treatment Revenue Share by Application (2021-2032) Figure 48. Europe Tuberculosis Vaccine Treatment Sales Share by Application (2021-2032) Figure 49. Europe Tuberculosis Vaccine Treatment Revenue Share by Country (2021-2032) Figure 50. Europe Tuberculosis Vaccine Treatment Sales Share by Country (2021-2032) Figure 51. China Tuberculosis Vaccine Treatment Revenue Share by Type (2021-2032) Figure 52. China Tuberculosis Vaccine Treatment Sales Share by Type (2021-2032) Figure 53. China Tuberculosis Vaccine Treatment Revenue Share by Application (2021-2032) Figure 54. China Tuberculosis Vaccine Treatment Sales Share by Application (2021-2032) Figure 55. Asia Tuberculosis Vaccine Treatment Revenue Share by Type (2021-2032) Figure 56. Asia Tuberculosis Vaccine Treatment Sales Share by Type (2021-2032) Figure 57. Asia Tuberculosis Vaccine Treatment Revenue Share by Application (2021-2032) Figure 58. Asia Tuberculosis Vaccine Treatment Sales Share by Application (2021-2032) Figure 59. Asia Tuberculosis Vaccine Treatment Revenue Share by Country (2021-2032) Figure 60. Asia Tuberculosis Vaccine Treatment Sales Share by Country (2021-2032) Figure 61. SAMEA Tuberculosis Vaccine Treatment Revenue Share by Type (2021-2032) Figure 62. SAMEA Tuberculosis Vaccine Treatment Sales Share by Type (2021-2032) Figure 63. SAMEA Tuberculosis Vaccine Treatment Revenue Share by Application (2021-2032) Figure 64. SAMEA Tuberculosis Vaccine Treatment Sales Share by Application (2021-2032) Figure 65. SAMEA Tuberculosis Vaccine Treatment Revenue Share by Country (2021-2032) Figure 66. SAMEA Tuberculosis Vaccine Treatment Sales Share by Country (2021-2032) Figure 67. Tuberculosis Vaccine Treatment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tuberculosis Vaccine Treatment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • Merck
  • Japan BCG Lab
  • Serum Institute of India
  • AJ Vaccines
  • BioFarma
  • GreenSignal Bio Pharma
  • China National Biotec
  • Biomed Lublin
  • Taj Pharmaceuticals
  • Ataulpho de Paiva
  • IVAC
  • Queen Saovabha Mem. Inst
  • Microgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tuberculosis Vaccine Treatment Market by Type
  3. 1.2.1 Global Tuberculosis Vaccine Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune Vaccine
  5. 1.2.3 Therapy Vaccine
  6. 1.3 Tuberculosis Vaccine Treatment Market by Application
  7. 1.3.1 Global Tuberculosis Vaccine Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Self-Procurement
  9. 1.3.3 UNICEF
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Tuberculosis Vaccine Treatment Market Dynamics
  1. 2.1 Tuberculosis Vaccine Treatment Industry Trends
  2. 2.2 Tuberculosis Vaccine Treatment Industry Drivers
  3. 2.3 Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccine Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tuberculosis Vaccine Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tuberculosis Vaccine Treatment Revenue by Region
  3. 3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tuberculosis Vaccine Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global Tuberculosis Vaccine Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tuberculosis Vaccine Treatment Sales by Region
  9. 3.4.1 Global Tuberculosis Vaccine Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tuberculosis Vaccine Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global Tuberculosis Vaccine Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers
  2. 4.1.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tuberculosis Vaccine Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tuberculosis Vaccine Treatment Sales by Manufacturers
  6. 4.2.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tuberculosis Vaccine Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tuberculosis Vaccine Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tuberculosis Vaccine Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tuberculosis Vaccine Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tuberculosis Vaccine Treatment Manufacturers, Product Type & Application
  13. 4.7 Global Tuberculosis Vaccine Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tuberculosis Vaccine Treatment Market CR5 and HHI
  16. 4.8.2 2025 Tuberculosis Vaccine Treatment Tier 1, Tier 2, and Tier 3
5 Tuberculosis Vaccine Treatment Market by Type
  1. 5.1 Global Tuberculosis Vaccine Treatment Revenue by Type
  2. 5.1.1 Global Tuberculosis Vaccine Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tuberculosis Vaccine Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tuberculosis Vaccine Treatment Sales by Type
  6. 5.2.1 Global Tuberculosis Vaccine Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tuberculosis Vaccine Treatment Sales by Type (2021-2032) & (K Dose)
  8. 5.2.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tuberculosis Vaccine Treatment Price by Type
6 Tuberculosis Vaccine Treatment Market by Application
  1. 6.1 Global Tuberculosis Vaccine Treatment Revenue by Application
  2. 6.1.1 Global Tuberculosis Vaccine Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tuberculosis Vaccine Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tuberculosis Vaccine Treatment Sales by Application
  6. 6.2.1 Global Tuberculosis Vaccine Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tuberculosis Vaccine Treatment Sales by Application (2021-2032) & (K Dose)
  8. 6.2.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tuberculosis Vaccine Treatment Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Tuberculosis Vaccine Treatment Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Japan BCG Lab
  8. 7.2.1 Japan BCG Lab Company Information
  9. 7.2.2 Japan BCG Lab Business Overview
  10. 7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
  12. 7.2.5 Japan BCG Lab Recent Developments
  13. 7.3 Serum Institute of India
  14. 7.3.1 Serum Institute of India Company Information
  15. 7.3.2 Serum Institute of India Business Overview
  16. 7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
  18. 7.3.5 Serum Institute of India Recent Developments
  19. 7.4 AJ Vaccines
  20. 7.4.1 AJ Vaccines Company Information
  21. 7.4.2 AJ Vaccines Business Overview
  22. 7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
  24. 7.4.5 AJ Vaccines Recent Developments
  25. 7.5 BioFarma
  26. 7.5.1 BioFarma Company Information
  27. 7.5.2 BioFarma Business Overview
  28. 7.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BioFarma Tuberculosis Vaccine Treatment Product Portfolio
  30. 7.5.5 BioFarma Recent Developments
  31. 7.6 GreenSignal Bio Pharma
  32. 7.6.1 GreenSignal Bio Pharma Company Information
  33. 7.6.2 GreenSignal Bio Pharma Business Overview
  34. 7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
  36. 7.6.5 GreenSignal Bio Pharma Recent Developments
  37. 7.7 China National Biotec
  38. 7.7.1 China National Biotec Company Information
  39. 7.7.2 China National Biotec Business Overview
  40. 7.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
  42. 7.7.5 China National Biotec Recent Developments
  43. 7.8 Biomed Lublin
  44. 7.8.1 Biomed Lublin Company Information
  45. 7.8.2 Biomed Lublin Business Overview
  46. 7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
  48. 7.8.5 Biomed Lublin Recent Developments
  49. 7.9 Taj Pharmaceuticals
  50. 7.9.1 Taj Pharmaceuticals Company Information
  51. 7.9.2 Taj Pharmaceuticals Business Overview
  52. 7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
  54. 7.9.5 Taj Pharmaceuticals Recent Developments
  55. 7.10 Ataulpho de Paiva
  56. 7.10.1 Ataulpho de Paiva Company Information
  57. 7.10.2 Ataulpho de Paiva Business Overview
  58. 7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
  60. 7.10.5 Ataulpho de Paiva Recent Developments
  61. 7.11 IVAC
  62. 7.11.1 IVAC Company Information
  63. 7.11.2 IVAC Business Overview
  64. 7.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 IVAC Tuberculosis Vaccine Treatment Product Portfolio
  66. 7.11.5 IVAC Recent Developments
  67. 7.12 Queen Saovabha Mem. Inst
  68. 7.12.1 Queen Saovabha Mem. Inst Company Information
  69. 7.12.2 Queen Saovabha Mem. Inst Business Overview
  70. 7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
  72. 7.12.5 Queen Saovabha Mem. Inst Recent Developments
  73. 7.13 Microgen
  74. 7.13.1 Microgen Company Information
  75. 7.13.2 Microgen Business Overview
  76. 7.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Microgen Tuberculosis Vaccine Treatment Product Portfolio
  78. 7.13.5 Microgen Recent Developments
8 North America
  1. 8.1 North America Tuberculosis Vaccine Treatment Market Size by Type
  2. 8.1.1 North America Tuberculosis Vaccine Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America Tuberculosis Vaccine Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America Tuberculosis Vaccine Treatment Price by Type (2021-2032)
  5. 8.2 North America Tuberculosis Vaccine Treatment Market Size by Application
  6. 8.2.1 North America Tuberculosis Vaccine Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America Tuberculosis Vaccine Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America Tuberculosis Vaccine Treatment Price by Application (2021-2032)
  9. 8.3 North America Tuberculosis Vaccine Treatment Market Size by Country
  10. 8.3.1 North America Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tuberculosis Vaccine Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tuberculosis Vaccine Treatment Market Size by Type
  2. 9.1.1 Europe Tuberculosis Vaccine Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tuberculosis Vaccine Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe Tuberculosis Vaccine Treatment Price by Type (2021-2032)
  5. 9.2 Europe Tuberculosis Vaccine Treatment Market Size by Application
  6. 9.2.1 Europe Tuberculosis Vaccine Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tuberculosis Vaccine Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe Tuberculosis Vaccine Treatment Price by Application (2021-2032)
  9. 9.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
  10. 9.3.1 Europe Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tuberculosis Vaccine Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tuberculosis Vaccine Treatment Market Size by Type
  2. 10.1.1 China Tuberculosis Vaccine Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China Tuberculosis Vaccine Treatment Sales by Type (2021-2032)
  4. 10.1.3 China Tuberculosis Vaccine Treatment Price by Type (2021-2032)
  5. 10.2 China Tuberculosis Vaccine Treatment Market Size by Application
  6. 10.2.1 China Tuberculosis Vaccine Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China Tuberculosis Vaccine Treatment Sales by Application (2021-2032)
  8. 10.2.3 China Tuberculosis Vaccine Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tuberculosis Vaccine Treatment Market Size by Type
  2. 11.1.1 Asia Tuberculosis Vaccine Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tuberculosis Vaccine Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia Tuberculosis Vaccine Treatment Price by Type (2021-2032)
  5. 11.2 Asia Tuberculosis Vaccine Treatment Market Size by Application
  6. 11.2.1 Asia Tuberculosis Vaccine Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tuberculosis Vaccine Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia Tuberculosis Vaccine Treatment Price by Application (2021-2032)
  9. 11.3 Asia Tuberculosis Vaccine Treatment Market Size by Country
  10. 11.3.1 Asia Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tuberculosis Vaccine Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tuberculosis Vaccine Treatment Market Size by Type
  2. 12.1.1 SAMEA Tuberculosis Vaccine Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tuberculosis Vaccine Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tuberculosis Vaccine Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA Tuberculosis Vaccine Treatment Market Size by Application
  6. 12.2.1 SAMEA Tuberculosis Vaccine Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tuberculosis Vaccine Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tuberculosis Vaccine Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA Tuberculosis Vaccine Treatment Market Size by Country
  10. 12.3.1 SAMEA Tuberculosis Vaccine Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tuberculosis Vaccine Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tuberculosis Vaccine Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tuberculosis Vaccine Treatment Value Chain Analysis
  2. 13.1.1 Tuberculosis Vaccine Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tuberculosis Vaccine Treatment Production Mode & Process
  6. 13.2 Tuberculosis Vaccine Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tuberculosis Vaccine Treatment Distributors
  9. 13.2.3 Tuberculosis Vaccine Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst